Molecular Formula | C23H25ClN2O |
Molar Mass | 380.92 |
Solubility | DMSO: ≥ 30 mg/mL |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.625 ml | 13.126 ml | 26.253 ml |
5 mM | 0.525 ml | 2.625 ml | 5.251 ml |
10 mM | 0.263 ml | 1.313 ml | 2.625 ml |
5 mM | 0.053 ml | 0.263 ml | 0.525 ml |
biological activity | HLCL-61 hydroxyapatite is the first small molecule protein arginine methyltransferase 5 (PRMT5) inhibitor. |
Target | Protein arginine methyltransfer 5 |
Cell Line: | MV4-11 cells, THP-1 cells, FLT3-WT blast (primary blasts from patients), FLT3-ITD blast (primary blasts from patients) |
Concentration: | 1, 5, 10, 25, 50, 100 μM |
Incubation Time: | 24, 48, 72 hours |
Result: | Dose-dependent reduction in cell viability with IC 50 s of 14.12, 16.74, 6.3, 8.72 μM for MV4-11 cells, THP-1 cells, FLT3-WT blast, and FLT3-ITD blast, respectively. |